

Postoperative pain (POP) is considered the
most typical form of acute pain.
Acute pain is the brief and intense pain that is generally cause and time
related with tissue damage.
It is the epiphenomenon of neurovegetative, psychological and behavioural
responses that lead to an unpleasant sensorial and emotional experience.
In the past pain therapy was practiced occasionally and approximately as most
medical and nursing staff and some patients too considered pain an unavoidable
component of normal postoperative progress.
Recent years have marked a growing interest in the prevention and treatment
of this syndrome.
In fact, progress in the physiopathology of pain and the pharmacology of analgesics,
the development of innovative and sophisticated antalgic methods, the demonstration
of complications related with pain symptoms and greater attention paid to
patients’ quality of life have contributed to spread the culture of “pain
therapy” and to make the problem known under its scientific aspects.
Despite this, today a considerable part of patients undergoing surgery continues
to experience avoidable suffering: a recent re-examination of scientific literature
reports an incidence of moderate to severe pain in 25-50% of patients who
undergo major surgery (thoracic, abdominal and orthopaedic) and moderate pain
in more than 25% of surgery outpatients. The international scientific community
basically agrees on the need to implement guidelines to treat postoperative
pain.
The SIAARTI [Italian Society for Anaesthetics Analgesia Resuscitation and
Intensive Care) has processed some warnings on this issue, starting from
the premise that postoperative pain control should become part of a treatment
plan for the “postoperative disease”.
This plan should consider pain the “fifth vital parameter” to be monitored
along with heart rate, arterial pressure, diuresis and body temperature.
PHYSIOPATHOLOGY OF ACUTE POSTOPERATIVE PAIN
Sensitivity
to pain is developed by a complex anatomical system comprising peripheral
receptors also called nociceptors that transduce painful stimuli, special
transmission routes, supraxial centres, which process algic inputs that start
along peripheral areas and descending routes by modulating and controlling
pain-related information.
Surgery’s attack on tissue activates the nociceptors present in the skin,
muscles and viscera.
Nociceptors are free endings of type A´ afferent fibres (myelinic fibre gauged
below 3¼ and a conduction speed of 12-30 m/s) and type C (amyelinic fibre
with a 1¼ diameter and a conduction speed of 0.5-2 m/s), whose cell body is
in ganglia connected to the spinal cord’s posterior root.
These ganglia (first level neurons) send their terminal axons to second level
neurons located in the posterior horns. These neurons’ terminal axons form
the lateral spinothalamic tract and synapses in the thalamus with third level
neurons.
These later originate fibers directed towards the somatosensory cortex. In
these terms nociceptors and ascending sensitive routes would be considered
an articulate system organized to receive and transmit the stimulus of pain.
In practice, progress made by research has revealed neurophysiological and
neurochemical events that control a greater functional complexity. In fact,
there are both peripheral and central sensitisation events that cause hyperalgesia,
which is an alteration of sensitivity that greatly emphasizes the intensity
of pain. Nociceptors are sensitised by chemical mediators that have an inflammatory
and vasoactive action (potassium, bradikynins, prostaglandins) and are released
by the cells and vascular endothelium in response to tissue damage. These
substances lower receptor excitement threshold and increase the discharge
frequency of afferent peripheral fibres, causing primary hyperalgesia.
The increased excitability of small fibres results in a greater presynaptic
release of neurotransmitters such as glutamate, substance P and neurokinins.
These neurotransmitters act both peripherally and spinally, amplifying the
response to pain. Substance P produces vasodilation that results from a further
release of bradykinin and mastcell degranulation, which releases histamine
and serotonin. These autacoids activate primary afferent nerves, sensitise
nociceptors near lesion sites and enlarge the field of peripheral reception.
This establishes a vicious circle that on the one hand contributes to maintain
primary hyperalgesia and on the other extends hyperalgesia to the lesion’s
neighbouring areas, generating secondary hyperalgesia. Axially the interaction
between neurotransmitters and receptors present on spinal neurone membranes
causes the appearance of slow post-synaptic potentials. As the activity of
afferent peripheral fibre gradually increases the release of neurotransmitters,
we notice a growing post-synaptic depolarization (neuronal wind up).
The persistence of these events produces permanent functional modifications
in dorsal horn neurones. These changes are clinically translated in prolonged
hyperalgesia and allodynia, pain caused by stimuli that are normally not painful
(fig.1).
Besides the ascending route, the system in charge of the nociception also
comprises descending routes that control pain. At least two groups of fibres
play a decisive role in the inhibiting modulation of pain: the opioid system
and the noradrenergic system. Receptors for endogenous opioids (encephalines
and ²-endorphines) and for amines (noradrenaline, serotonin) are variously
distributed in the CNS both spinally and supraspinally, especially in the
grey matter around the brain acqueduct, in the reticular formation and in
the raphe nucleus.
Opioid and noradrenergic neurotransmitters share the same method of action
on first level neurone presynaptic membranes: the agonist and receptor interaction
hyperpolarizes afferent fibres preventing the propagation of the painful stimulus
and the release of glutamate, substance P and neurokinin exciting neurotransmitters.
Besides it seems that endogenous opioids intervene in pain modulation even
with post-synaptic inhibition mechanisms. Exogenous opioids and recently ±2
agonist drugs have an analgesic action as they interact with the central and
spinal receptors that are naturally involved in the inhibiting modulation
of pain.
From what has been described it is obvious that the knowledge of acute post-operative
pain’s physiopathology is the premise for the rational use of analgesic drugs
that have different methods of action and for the choice between the method
and time of administration that can be applied.
ACUTE PAIN ITS SYSTEMIC EFFECTS
Besides,
from a typically ethical viewpoint adequate post-operative analgesia is important
against the harmful effects pain exercises on various organs and systems.
Tissue lesion causes important physiopathological alterations typical of the
“stress reaction” that can be put down to reflex responses triggered by the
pain stimulus along the afferent sensitive route. Spinally the arrival of
algic input activates, as a reflex, the anterior dorsal horn’s somatomotor
and preganglionic neurons with subsequent hypertonic skeletal muscles and
autonomic hyper-reactivity.
The hypothalamus, which is directly related with pain sensitive routes, causes
suprasegmentary reflex responses that result in deep neuroendocrine alterations,
which are characterized by the incretion of catabolic hormones such as catecholamines,
cortisol, angiotensin II, GH and glucagon and the inhibition of anabolic hormones
such as testosterone and insulin.
Lastly cortical circuits are at the basis of psychopathological processes
such as anxiety, insomnia, discomfort and voluntary immobility due to the
fear of aggravating pain-related symptoms that accompany the conscious perception
of pain. Clinically speaking hypermetabolism leads to a negative nitrogen
balance and to increased oxygen consumption.
The cardiovascular system’s involvement in the stress reaction can be extremely
dangerous: catecholamines and angiotensin II can lead to myocardial ischaemia
by increasing the heart’s work, while concomitant water retention promoted
by aldosterone, ADH and cortisol can precipitate episodes of heart failure
in patients with reduced reserves.
The respiratory system too is particularly exposed to the negative effects
of pain: the accumulation of liquids in pulmonary interstices and the reflex
increased skeletal muscle tone in surgical wounds located in the chest and
high abdominal region can compromise normal respiratory functions and encourage
the onset of pulmonary complications.
Autonomic hyperactivity is accompanied by smooth muscle paralysis with negative
effects in the gastroenteric and genitourinary systems: the nausea and vomit
related with post-operative ileum delay and the resumption of enteral feeding,
while urinary retention exposes to the risk of infections.
Even coagulation changes in stress response: haematic hyperviscosity and platelet
tendency to aggregate increase the incidence of thromboembolic events. Lastly
many mediators released in response to pain depress the immune response, encouraging
the onset of complications of an infectious nature. The many pain related
adverse events have a negative impact on the outcome and comfort of patients:
postoperative morbidity and mortality are increased and delayed action is
evident in increased hospitalisation periods and costs.
TREATMENT
Physiopathological
know how on the origin of pain has contributed to the clinical introduction
of certain concepts, leading to progress in the traditional procedure that
considered pain simply as a symptom to be treated.
The knowledge of dynamic events that amplify and also distort the painful
input has introduced the concept of preemptive analgesia in antalgic treatment,
in other words the need to establish precocious antalgic treatment before
the onset of symptoms to prevent neurophysiological modifications, which are
at the basis of peripheral and medullary hyperexcitability. It is thus possible
to ensure an adequate analgesic plan by acting during the preparatory phase
or however before the nociceptive stimulus begins, in order to delay or attenuate
the pain-related symptoms and prevent events related with the formation of
the spinal memory of pain (preemptive analgesia).
Analgesia is then continued during and after surgery on the basis of the variability
of painful stimuli and related symptoms. Multimodal analgesia is another concept:
it is an approach based on the combined use of multiple drugs administered
with different methods and at different preoperative moments. By exploiting
the synergic effect of many drugs with different methods of action the multimodal
approach minimizes the side effects typical of single drug treatment and enables
to intervene at various levels of the ‘pain route’, guaranteeing better quality
analgesia.
Drug treatment is essentially based on three classes of drugs: NSAIDs, opioid
analgesics and local anaesthetics. NSAIDs block the cyclooxygenase route,
thus inhibiting the synthesis of prostaglandins (PG) involved in sensitising
peripheral nociceptors and in hyperalgic events; administered systemically
they are probably the most frequently used drugs to control post-operative
pain. They are effective in treating mild to moderate pain, but administered
alone they cannot control pain in major surgery. In these cases they can be
used as adjuvants as they can lessen the discomfort and hence the side effects
of opiates, thus improving the quality of the analgesia.
We must mention that NSAIDs prevent the formation of new PG, while the PG
already released continue to exercise their hyperalgic effects. Hence the
most effective use of non-steroid analgesics lies in the prevention of pain.
The reduction of prostaglandins, which is the basis of the therapeutic effect,
also causes the main undesired effects related with the use of NSAIDs: erosion/gastrointestinal
ulcers, renal failure and haemorrhagic complications.
As already stated previously NSAIDs blocking the cyclooxygenase route, thus
inhibiting the synthesis of PG involved in the sensitisation of peripheral
nociceptors and in hyperalgic events, but the cyclooxygenase enzyme has two
forms (COX-1 and COX-2). COX-1 is a representative product of healthy cells
and promotes the synthesis of PG involved in normal cellular functions such
as the production of gastric mucus, the maintenance of renal haematic flow
and platelet aggregation. COX-2 is instead the inducible enzyme and it is
produced during inflammatory conditions. PGs synthesized by COX-2 are directly
involved in the modulation of the inflammatory response and of the transmission
of painful stimuli. NSAIDs’ inhibition ratio between COX-1 and COX-2 will
decide the appearance of undesired effects. For this reason studies have focused
on identifying COX-2.4, 5 specific inhibitors. The existence
of a third isoenzyme (COX-3) was recently discovered.
Experimental studies concerning its role are still underway - they could lead
to new generation NSAIDs. It seems that paracetamol’s method of action, a
well-known NSAID with powerful analgesic and antipyretic effects but with
hardly any effects on gastric mucus and on platelets, is related with the
inhibition of COX- 3. 7,8
Opiates are certainly the most powerful analgesic drugs, to the point that
they represent the stronghold of antalgic treatment in moderate to severe
pain as they directly act on the central systems involved in modulating the
nociceptive stimulus. The effects of opioids depend on the interaction with
specific receptors (¼1,¼2,º,´,Ã,µ) variously distributed in the brain and
the spinal cord. The pharmacological profiles of opioid receptors are now
well documented. ¼1 receptors produce analgesia by acting at a supraspinal
level, while ´ and º receptors alleviate pain through spinal mechanisms. Undesired
effects related with analgesic opioid treatment are none other than an extension
of the pharmacological activity, especially respiratory depression, which
is the most feared complication; it is a response mediated by the receptor
¼2.
Other consequences of receptor activation comprise myosis (¼1,º), feeling
of well being (¼1), reduced gastrointestinal motility (¼2), nausea and vomit
(¼1, ´), itching (¼1, ´), sedation (¼1, º), dysphoria and hallucinations (Ã),
tolerance and physical dependence (¼1,´,º).
Analgesic opioids are classified on the basis of the activity and attraction
towards receptors as agonists, antagonists, partial agonists and mixed agonists.
Pure agonist drugs (Morphine, Meperidine, Fentanyl, Remifentanyl, etc.) are
the most used in antalgic treatment.
Despite being relatively selective towards ¼ receptors they have a moderate
activity on other receptor categories (º, ´), which explains their spinal
and supraspinal analgesic properties and also their undesired dose-related
reactions and potential additive effect. The presence of endogenous opioid
peptide receptors in the dorsal horn is at the basis of these drugs’ use for
spinal analgesia, which offers the advantage, when compared to the systemic
route, of reaching a high drug concentration directly on the site of action.
Local anaesthetics are administered to obtain both peripheral and central
nervous blocks when treating acute pain.
They block action potentials that conduct the impulse by interacting with
the ionic channels present in nervous fibres, thus reversibly interrupting
afferent sensitive nerve endings. When they are applied to a nerve or its
immediate neighbourhood they cause a total sensitive block and motor paralysis;
when administered directly at a spinal level they also induce an autonomic
block, with subsequent neurovegetative effects. From the moment local anaesthetics,
besides blocking the conduction in peripheral nerves, also interfere with
the functions of organs in which the impulse is conducted there can be adverse
reactions in the CNS, myocardium, neuromuscular junctions and the entire muscular
system. This danger is obviously proportionate with the drug’s plasma concentrations
that are reached after absorption. Hence it is obvious that the ideal anaesthetic
for postoperative analgesia must be long-acting with low systemic toxicity
and it must preferentially induce a sensitive block. Ropivacaine, which boasts
these features, is currently the first choice anaesthetic to be used for antalgic
purposes.
Besides local anaesthetics, a block of the nervous conduction of painful stimuli
in peripheral nerves and posterior roots prevents the onset of central sensitisation
events. The nervous block around the surgical wound has hence the double advantage
of suppressing pain and of effectively preventing sensitisation-related events.
The subaracnoid route is hardly used for analgesic purposes due to the danger
of infectious complications associated with the presence of a catheter in
close contact with the cephalorachidean route. The epidural route, which is
more suitable for continuous catheter infusion, is generally preferred.
Epidural administration of opioids and local anaesthetics ensures an adequate
analgesic plan with a lower incidence of undesired effects. Since the two
drugs intervene at different levels along the circuits involved in pain transmission,
the association enables to use lower doses than those required if they were
each used alone. The substantial advantage of introducing drugs directly into
the spine has lead to study new molecules that can interfere with the medullary
pain transmission process.
These also number alpha 2 agonists - the most famous one is clonidine, which
is already used clinically. Alpha 2 adrenergic receptors are located on primary
afferent nerve endings, bone marrow neurons and neurons of the trunk implied
in analgesia. All this supports the theory of a spinal and supraspinal analgesic
action. It has in practice been proved that alpha 2 agonists inhibit the excitability
of primary afferent fibres and reduce the release of algogenic neurotransmitters
like substance P in the dorsal horn. The locus coeruleus instead, which is
in charge of sedative effects too, is supposed to be involved in supraspinal
mechanisms. 11
It has recently been proved that the analgesic effect of alpha 2 adrenergic
agonists could be mediated by different receptor subtypes. This theory opens
the way for the study of selective drugs that only have an analgesic effect,
avoiding hypotension and sedation. A special method of administration called
PCA (Patient Controlled Analgesia) has been perfected due to the difficulty
in controlling pain when anaesthesia wears out and the variables related with
the type of surgery and individual diversities.
This method, used for intravenous, epidural and perineural administration,
optimizes analgesia by enabling the patient to independently handle drug administration
according to the fluctuation of painful symptoms, thanks to the availability
of manual, elastomeric (fig.
2,3) and electronic pumps equipped with a control module for
the self administration of additional loads. This treatment is obviously programmed
by the doctor, who decides the drug type, concentration, timings and maximum
dosage that can be administered (fig.4).
The choice of analgesic technique obviously depends on the intensity of the
pain and the site of surgery. In mild and moderate pain the simplest approach
consists in systemically administering a non-steroid, anti-inflammatory drug,
associated or not with an opiate. At least during the period that directly
follows surgery the intravenous route (repeated loads, continuous infusion)
should be preferred to the oral or intramuscular ones as it enables to rapidly
reach the effective plasma concentration. More complex techniques such as
epidural analgesia must be applied in those patients for whom severe pain
is expected. Continuous peripheral nervous blocks are applied in the treatment
of moderate and severe pain obviously only when the use of a local/regional
anaesthetic is specified.
Postoperative pain (POP)
IN ORTHOPAEDIC SURGERY
In
the orthopaedic and traumatology field the treatment of acute postoperative
pain is of particular importance considering certain typical features of this
specialized surgery. Generally speaking orthopaedic surgery is accompanied
by an impressive phlogistic and algogenic reaction, whose intensity depends
on the extent of the area operated. Besides postoperative pain can influence
the functional recovery of the skeletal district operated, negatively influencing
the patient’s rehabilitation and outcome.
The problem concerning the expense of health services and the improvement
of anaesthetic and surgical techniques has also changed the scenario of orthopaedic
surgery, recording in recent years a remarkable increase in the number of
outpatients’ surgery. Local/regional techniques (nervous peripheral blocks,
central blocks) are extensively applied both for anaesthetic and antalgic
purposes due to surgical site features. In postoperative pain control they
offer the advantage of a minor endocrine-metabolic response to surgical stress
and are more effective than the systemic administration of analgesics in preventing
the inducement of hypersensitivity to pain, according to preemptive analgesia
theories.
In upper and lower limb surgery nervous peripheral blocks (anaesthesia of
the plexus, anaesthesia of the trunk) enable to obtain the best compromise
between good operating conditions, adequate analgesia and the patient’s safety
and comfort. However the abatement of painful symptoms is limited to at least
24 hours after surgery when a single peripheral block is applied.
The introduction of a catheter in the vascular-nervous tract when the block
is created (fig.5,
6,7,8), the use of pumps for continuous infusion and for PCA
techniques together with a sufficiently high therapeutic index and the availability
of long-acting local anaesthetics that can selectively induce a sensitive
block have enabled to prolong regional anaesthesia in the post-operative period,
ensuring satisfactory results.
Many studies confirm the use of continuous perineural analgesia in certain
surgical sites: reduction of hospitalisation period, minor incidence of anaesthesia
related complications, better control of POP related with a reduced need for
opioid or anti-inflammatory analgesics and quick functional recovery are the
main advantages of this type of approach.15,16 The continuous
peripheral block has proved effective and safe also in outpatient surgery.
Lumbar rachianaesthesia, both subaracnoid and peridural, is recommended in
surgery of the hip and the entire lower limb. Often in orthopaedics, variables
that limit indications are added to traditional contraindications: long operations,
the use of bloody and noisy tools, uncomfortable posture on the operating
table and the need for invasive haemodynamic monitoring.
The general preference is for balanced anaesthesia that associates general
anaesthesia (hypnosis) with the epidural block (analgesia). Continuous PCA
epidural infusion of opioids and local anaesthetics is certainly an effective
analgesic treatment in major orthopaedic surgery. After hip prosthesis surgery
84.3% and 85.7% of patients respectively subject to balanced anaesthesia and
epidural anaesthesia alone do not present pain, while moderate to severe pain
is recorded in 34.3% of patients subject to general anaesthesia. 20
Epidural anaesthesia also offers good bleeding control during and after surgery
and reduces thromboembolic complications, which are some of the most feared
events in major orthopaedic surgery.
Besides there are no studies that make a comparison between the extent of
bleeding and especially of postoperative pain in local/regional anaesthetic
techniques and modern general anaesthetic methods that make use of increasingly
selective anaesthetic drugs, which are effective and have an increasingly
good tolerance profile.
A study still underway at the Istituto ortopedico G. Pini shows that the anaesthetic
method adopted in knee arthroscopic surgery influences post-operative progress
concerning pain: the important fact is that an adequate POP control is always
obtained, but patients subject to general anaesthesia present a greater request
for analgesics than the group that undergoes local/regional anaesthesia.
However this preliminary data reveals a difference also related to the many
general anaesthesia techniques adopted
(fig. 9,10). Considering local/regional techniques, the insertion
of a catheter in the peridural space is an invasive manoeuvre that requires
specialized manual skills and is aggravated by complications that contraindicate
its use in certain patients (i.e. treatment with heparin): in these cases
intravenous PCA with opioid and anti-inflammatory analgesics is a valid alternative
in the treatment of severe pain.21.
We must however specify that systemically administered opioids do not alter
response to surgical stress (except in dosages that significantly depress
the respiratory function), while epidural analgesia, besides reducing post-operative
catabolic response, also ensures dynamic analgesia, thus enabling precocious
mobilization. Though local-regional techniques have proved to be a winning
strategy in post-operative pain control (POP), we must not neglect the need
to administer anti-inflammatory drugs systemically.
NSAIDs are essential considering the remarkable phlogistic reaction typical
of orthopaedic surgery. Used alone they can check mild pain in minor surgery,
while they are associated with opioid analgesics in very intense pain. But
their use is limited to the need to prevent bleeding, especially in major
surgery.
The recent availability of COX-2 specific inhibitors enables to overcome these
limits.
Systemic drugs can obviously integrate local-regional methods when the latter
prove inadequate. Concluding, orthopaedic surgery with its need to access
almost all body districts represents a wide field of application for the many
antalgic techniques currently available.
Renato
Coluccia
Primario
Senior Consultant
Alfonso D’Aloia, Sabrina Basilico
Servizio di Anestesia, Rianimazione e Terapia del Dolore Anaesthetics, Intensive
Care and Pain Therapy
Istituto Ortopedico Gaetano Pini, Milano
